Detalles de la búsqueda
1.
Efficacy and Safety of Nimotuzumab in Combination with Radiotherapy or Chemoradiotherapy for Local Advanced Head and Neck Cancer: A Systematic Review and Meta-analysis.
Curr Cancer Drug Targets
; 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38549541
2.
MicroRNA-137 Inhibits Esophageal Squamous Cell Carcinoma by Downregulating DAAM1.
Protein Pept Lett
; 29(10): 882-890, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35986526
3.
Development and validation of a model to predict the risk of recurrence in patients with laryngeal squamous cell carcinoma after total laryngectomy.
Ann Transl Med
; 10(20): 1118, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36388789
4.
First-Line Chemoradiation With or Without Chidamide (Tucidinostat) in Patients With Intermediate- and High-Risk Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma: A Randomized Phase 2 Study in China.
Int J Radiat Oncol Biol Phys
; 113(4): 833-844, 2022 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35452752
5.
Prognostic Nutritional Index, Another Prognostic Factor for Extranodal Natural Killer/T Cell Lymphoma, Nasal Type.
Front Oncol
; 10: 877, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32637354
6.
Hemoglobin level, a prognostic factor for nasal extranodal natural killer/T-cell lymphoma patients from stage I to IV: A validated prognostic nomogram.
Sci Rep
; 7(1): 10982, 2017 09 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28887511
7.
A comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages: The efficacy of CHOP regimen based concurrent chemoradiotherapy.
Oncotarget
; 8(12): 20362-20370, 2017 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-27901491
8.
[The predictive value of Ki-67 expression for prognosis in patients with extranodal nasal type NK/T-cell lymphoma].
Zhonghua Xue Ye Xue Za Zhi
; 36(7): 612-4, 2015 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-26304090
Resultados
1 -
8
de 8
1
Próxima >
>>